Fig. 4From: Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysisForest plot for the correlation between sPLA2R-ab and the rate of clinical remission based on assay methods (a), ethnicity (b), gender (c), and renal function (d)Back to article page